Infectious Disease Assay Portfolio
|
From HIV and hepatitis to ToRCH infections,
syphilis, and sepsis, the Atellica infectious disease portfolio supports
laboratories with trusted ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...